Original language | English |
---|---|
Pages (from-to) | 1327-1348 |
Number of pages | 22 |
Journal | The Journal of Heart and Lung Transplantation |
Volume | 40 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2021 |
Keywords
- complications
- expert recommendations
- lung transplantation
- primary graft dysfunctions
- survival
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Journal of Heart and Lung Transplantation, Vol. 40, No. 11, 11.2021, p. 1327-1348.
Research output: Contribution to journal › Article › Other › peer-review
TY - JOUR
T1 - International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document
AU - Marczin, Nandor
AU - de Waal, Eric E.C.
AU - Hopkins, Peter M.A.
AU - Mulligan, Michael S.
AU - Simon, Andre
AU - Shaw, Andrew D.
AU - Van Raemdonck, Dirk
AU - Neyrinck, Arne
AU - Gries, Cynthia J.
AU - Algotsson, Lars
AU - Szegedi, Laszlo
AU - von Dossow, Vera
AU - Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members):
AU - Burrell, Aidan
AU - Carmona, Paula
AU - Greenhalgh, Donna
AU - Höchter, Dominik
AU - Kachulis, Bessie
AU - King, Christopher S.
AU - Licker, Marc J.
AU - McIlroy, David R.
AU - Nair, Priya
AU - Pasero, Daniela
AU - Pilcher, David
AU - Rex, Steffen
AU - Royston, David
AU - Slinger, Peter
AU - Valenza, Franco
AU - Walker, Chris
AU - Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members):
AU - Arcadipane, Antonio
AU - Bastien, Oliver
AU - Bekkers, Joseph A.
AU - Bettex, Dominique
AU - Caliandro, Francesca
AU - Checco, Erika Dal
AU - Davis, Robert Duane
AU - Dellgren, Göran
AU - Espinoza, Andreas
AU - Felten, Marie Louise
AU - Feltracco, Paolo
AU - Fischler, Marc
AU - Fitzgerald, Linda J.
AU - Forner, Ana Flo
AU - Fragata, Isabel
AU - Román, Ana González
AU - Harris, Paul
AU - Hommel, Matthias
AU - Lees, Nicholas J.
AU - Guen, Morgan Le
AU - Leone, Marc
AU - Lepoivre, Thierry
AU - Marcucci, Carlo
AU - Martelli, Sabina
AU - Michel-Cherqui, Mireille
AU - Molitoris, Ulrich
AU - Montravers, Philippe
AU - Mosca, Roberto
AU - Parizkova, Barbora
AU - Prabhu, Mahesh
AU - Pugliese, Francesco
AU - Raman, Sanjeev M.
AU - Ramos, Cristina
AU - Ranieri, Vito Marco
AU - Real, Maria I.
AU - Ricksten, Sven Erik
AU - Roman, Ana Gonzalez
AU - Rozec, Bertrand
AU - Sale, Shiva M.
AU - Sanchez, Juan F.
AU - Schwarzenberger, Johanna
AU - Turan, Sema
AU - Valchanov, Kamen
AU - Valentine, Vincent G.
AU - von Homeyer, Peter
AU - Vuylsteke, Alain
AU - Weig, Thomas
AU - Zarragoikoetxea, Iratxe
AU - Zenz, Sebastian
AU - Falcoz, Pierre Emmanuel
AU - Inci, Ilhan
AU - Roscoe, Andrew
AU - Senturk, Mert
N1 - Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Nandor Marczin reports personal fees from Linde, grants and personal fees from Cytosorbents Inc, outside the submitted work. Eric E.C. de Waal reports personal fees from Abbott, grants and personal fees from Cytosorbents, outside the submitted work. Andrew D. Shaw reports personal fees from Edwards Lifesciences, from FAST BioMedical, and from Astellas Pharma, outside the submitted work. Vera von Dossow reports speakers’ fees from Orion Pharma outside the submitted work. Christopher King reports personal fees from Actelion, Genentech, United Therapeutics, and Boehringer Ingelheim Pharmaceuticals, outside the submitted work. Steffen Rex reports personal fees from Orion Pharma and Edwards Lifesciences, grants and personal fees from Nordic Pharma, grants from AirLiquide, outside the submitted work. Göran Dellgren reports grants from Astellas for ScanCLAD study (ClinicalTrials.gov Identifier: NCT02936505), grants from Abbott for SweVAD study (ClinicalTrials.gov Identifier: NCT02592499), personal fees from XVIVO speakers bureau, outside the submitted work. Ana González Román reports economical support from Abbott and Orion Laboratories, outside the submitted work. Morgan Le Guen reports personal fees from General Electric, and Fisher and Paykel, outside the submitted work. Marc Leone reports personal fees from MSD, Amomed, Aspen, and Gilead, outside the submitted work. Bertrand Rozec reports personal fees from LFB, AMOMED, Nordic Pharma, Medtronic, 3M, Aspen, and grants from Aguettant and Baxter, outside the submitted work. Shiva M. Sale reports speaker fees from St Jude, outside the submitted work. Robert Duane Davis and Vincent G. Valentine did not disclose conflict of interests. All other authors have no disclosures to report.
PY - 2021/11
Y1 - 2021/11
KW - complications
KW - expert recommendations
KW - lung transplantation
KW - primary graft dysfunctions
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85121606778&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2021.07.012
DO - 10.1016/j.healun.2021.07.012
M3 - Article
C2 - 34732281
AN - SCOPUS:85121606778
SN - 1053-2498
VL - 40
SP - 1327
EP - 1348
JO - The Journal of Heart and Lung Transplantation
JF - The Journal of Heart and Lung Transplantation
IS - 11
ER -